| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.3M | — | -17.0% |
| Cost of Revenue | $18.5M | — | -23.7% |
| Gross Profit | -$1.2M | — | +64.4% |
| R&D Expense | $1.1M | — | +21.0% |
| SG&A Expense | $8.0M | — | +58.3% |
| Operating Income | -$12.1M | — | -14.2% |
| Interest Expense | $3.9M | — | +448.0% |
| Pre-tax Income | $32.8M | — | +1019.9% |
| Income Tax | $195K | — | -23.2% |
| Net Income | $32.6M | — | +953.6% |
| EPS (Basic) | $2.09 | — | +796.7% |
| EPS (Diluted) | -$0.72 | — | -24.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.6M | -73.3% | -4.6% |
| Accounts Receivable | $56.4M | +1.2% | +27.5% |
| Inventory | $9.4M | -2.1% | +38.0% |
| Current Assets | $83.8M | -14.3% | +17.9% |
| Total Assets | $97.8M | -12.5% | +16.4% |
| Current Liabilities | $63.4M | -7.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.8M | — | -50.6% |
| Capital Expenditures | $276K | — | +232.5% |
| Investing Cash Flow | -$276K | — | -108.8% |
| Financing Cash Flow | -$2.4M | — | — |
| Free Cash Flow | -$13.0M | — | -52.3% |
| +24.7% |
| Long-term Debt | $12.9M | +29.9% | +26.7% |
| Total Liabilities | $104.0M | -32.8% | +51.7% |
| Stockholders' Equity | -$6.1M | +85.7% | -139.6% |